ArticlePlastic and reconstructive surgery. Global open2026
Exploring Exosomes for Pediatric Ischemic Auricular Flap Repair.
Article in Plastic and reconstructive surgery. Global open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Application of stem cell-derived exosomes in skin wound healing: mechanisms, prospects, and challenges.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Avulsions of the upper third of the ear often present with skin flaps of compromised vascularity. Although initially viable, these flaps may later develop ischemic changes ranging from epidermolysis to full-thickness necrosis, delaying healing. Angiogenesis, primarily mediated by vascular endothelial growth factor (VEGF), is essential for tissue repair. In children, VEGF promotes endothelial cell migration and proliferation, accelerating wound healing. Currently, VEFG is the primary target of therapeutic angiogenesis approaches, and microRNAs have emerged as key angiogenic regulators. Exosomes have gained relevance in regenerative medicine as paracrine mediators of skin repair. VEGF expression peaks between days 3 and 7 after injury; hypothetically, this VEGF window is considered optimal for delivering proangiogenic exosome cargo directly to the ischemic skin flap. By providing microRNA-mediated proangiogenic signals early in the healing process, exosomes may enhance tissue perfusion and improve flap survival. We report the case of a 10-year-old girl with a partial soft-tissue degloving injury of the upper third of the auricle. The avulsed flap had folded onto itself, causing venous congestion. After repositioning, flap distal congestion persisted and progressed to partial tissue necrosis by postoperative day 3. The wound was treated with
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.